SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Swing Trading With Options
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: underdog430 who started this subject7/27/2001 6:18:54 PM
From: underdog430   of 88
 
I think that it's interesting to see how news on AVIR progressed over the day:

Jul 27 2001
3:05 PM In Play Aviron (AVIR) 40.80 unch: -- Update -- The FDA panel voted 10 to 4 against recommending FluMist, citing safety issues. AVIR shares remain halted.

Jul 27 2001
2:57 PM In Play Amer Home Prods (AHP) 57.70 -1.23: Issue falls approximately 3 pts on an intraday basis as reports come in that Aviron's (AVIR) FluMist vaccine was not backed by an FDA panel. FluMist was to be co-marketed by AHP.

Jul 27 2001
1:13 PM In Play Aviron (AVIR) 40.80 unch (halted): -- Update -- Issue continues to be held as FDA panel reviews company's FluMist investigational intranasal influenza vaccine. Sources at SG Cowen telling us that the Committee considered the drug efficacious by a vote of 13 to 2. While vote on efficacy in children aged 1-17 was more involved (8 to 7), of the 7 no votes, 5 panelists stated they would have voted in favor if efficacy had children age 1 been excluded. Firm views these results as positive for AVIR.

Jul 27 2001
8:55 AM In Play Aviron (AVIR) 40.80: SG Cowen reports that the first day of FDA FluMist BLA review went well. Believes likely outcome is an approval for healthy children and adults ages 1-64.

I'm looking forward to seeing how this plays out on Monday. Trading based on FDA reviews seems especially appealing for short term option trades since the FDA has a publicly known timeline and time is, of course, a major element of option trading. TradingMarkets.com has a two-part article on "Trading the FDA", part two of which is scheduled to be posted on August 11. Any suggestions for how to follow this group?

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News